Posts Tagged 'Johnson & Johnson'

FDA panelists wouldn’t recommend metal implants

According to a story on WLFI out of Indiana, most members of a U.S. FDA panel said they would not recommend metal-on-metal implants for patients who needed hip replacement surgery.

The report quotes a physician on the panel as saying: “I do not use metal-on-metal hips, and I can see no reason to do so.”

At the FDA’s request, the 18-member panel of experts met for two days this week to discuss ...

continue reading...

New J&J CEO involved in previous recall

A Newark Star-Ledger profile of Alex Gorsky, the new CEO of Johnson & Johnson, describes him as “the go-to man” during the company’s 1998 recall of Hismanal, an antihistamine that proved to have dangerous cardiovascular side effects.

Gorsky has succeeded previous chief executive officer William Weldon, who stepped down after a disastrous series of recalls. But the Star-Ledger mentions that some industry observers are questioning whether Gorsky played a part in marketing a hip implant that has generated thousands of lawsuits ...

continue reading...

Study: More research needed on hip implants, cancer

The BBC reports that a British study found no evidence of a link between metal-on-metal hip implants and cancer. But the analysis of 41,000 patients covered only seven years following hip replacement surgery, and researchers said follow-up will be necessary.

Medical professionals are concerned about the long-term impact of cobalt and chromium ions breaking off the implants and getting into patients’ blood and soft tissues.

Researchers in the U.K. have already drawn on data from the National Joint Registry of England and ...

continue reading...

Departing Johnson & Johnson CEO Weldon getting $143.5 million

Departing Johnson & Johnson Chief Executive Officer William C. Weldon, who is leaving after a spate of disastrous recalls, will get $143.5 million in retirement pay, according to Bloomberg.

Bloomberg reports that Weldon, 63, will remain chairman. He amassed $95.1 million in deferred and long-term compensation during his 40 years with the company, and his pension has a present value of $48.4 million.

The report mentions that the company struggled with recalls of artificial hip implants and over-the-counter drugs, and safety concerns ...

continue reading...

Recalls a factor in CEO’s departure

An Associated Press story about the imminent retirement of longtime Johnson & Johnson CEO Bill Weldon mentions his company’s succession of product recalls over the last two years.

Weldon became the company’s CEO in 2002.

According to the story, there were more than two dozen recalls of nonprescription drugs and at least two for prescription drugs since 2009.

There were also recalls of about 25 medical devices and consumer products. Federal regulators have had three of the company’s factories under scrutiny, and shut ...

continue reading...
Page 24 of 24 «...102021222324